Relationship Between Some Cardiovascular Risk Factors (Hypertension and Diabetes) and Hearing Loss: A Review and Critical Appraisal
Main Article Content
Abstract
Cardiovascular disease and its risk factors are no longer only problems in developed countries, they are equally prevalent in developing countries. Cardiovascular risk factors have been hypothesized to play a role in the pathogenesis of hearing loss. Specifically, hypertension and diabetes mellitus can affect the cochlear microvasculature, leading to cochlear atherosclerosis. These atherosclerotic changes may result in impairment of local micro-cochlear circulation, causing ischemia and necrosis of the stria vascularis, hair cells, and the entire organ of Corti, and this may lead to hearing loss. The effect of cardiovascular risk factors on hearing is still under investigation. The aim of this study is to review the relationship between cardiovascular risk factors (hypertension and diabetes) and hearing loss.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. American Heart Association. International Cardiovascular Disease Statistics. 2007 Update. Available at: http://www.americanheart.org/presenter.jhtm
II. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004;291;2616 –2620.
III. Ezzati M, Vander Hoorn S, Lawes CM, Leach R, James WP, Lopez AD, Rodgers A, Murray CJ. Rethinking the “diseases of affluence” paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med 2005; 2:e133.
IV. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–223.
V. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414:782–787.
VI. Armas-Padrón AM, Sicilia-Sosvilla M, Ruiz-Esteban P, Torres A, Hernández D. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population. Nefrología. 2022 Dec 15.
VII. Cheung CY, Zheng Y, Hsu W, Lee ML, Lau QP, Mitchell P, Wang JJ, Klein R, Wong TY. Retinal vascular tortuosity, blood pressure, and cardiovascular risk factors. Ophthalmology. 2011 May 1;118(5):812-8.
VIII. Tan HE, Lan NS, Knuiman MW, Divitini ML, Swanepoel DW, Hunter M, Brennan‐Jones CG, Hung J, Eikelboom RH, Santa Maria PL. Associations between cardiovascular disease and its risk factors with hearing loss—a cross‐sectional analysis. Clinical Otolaryngology. 2018 Feb;43(1):172-81.
IX. hypertension. Hypertension. 2012: 60(5); 1088–1093.
X. Yıldırım N. Hearing impairment in vascular disorders. Van Medical Journal. 2012; 19(3):149–157.
XI. World Health Organization. Deafness and hearing loss. Geneva: WHO; 2021. www.who.int/news-room/fact-sheet/detail/deafness-and-hearing loss.
XII. Olusanya BO, Neumann KJ, Saunders JE. The global burden of disabling hearing impairment: a call to action. Bull World Health Organ 2014; 92:367–373.
XIII. Adamu A, Ajiya A, Abdullahi H, Hasheem MG, Bello-Muhammad N. Adherence to protective measures against hearing related hazards of mobile phone users among university students. Niger J Med 2020;29(2):312-6.
XIV. Oron Y, Elgart K, Marom T, Roth Y. Cardiovascular risk factors as causes for hearing impairment. Audiology and Neurotology. 2014 Oct 1;19(4):256-60.
XV. Friedland DR, Cederberg C, Tarima S. Audiometric pattern as a predictor of cardiovascular status: development of a model for assessment of risk. Laryngoscope 2009;119: 473–486.
XVI. Przewoźny T, Gójska-Grymajło A, Kwarciany M, Gąsecki D, Narkiewicz K. Hypertension and cochlear hearing loss. Blood pressure. 2015 Jul 4;24(4):199-205
XVII. Nawaz MU, Vinayak S, Rivera E, Elahi K, Tahir H, Ahuja V, Jogezai S, Maher W, Naz S. Association Between Hypertension and Hearing Loss. Cureus. 2021 Sep 16;13(9).
XVIII. Samelli AG, Santos IS, Padilha FY, et al.: Hearing loss, tinnitus, and hypertension: analysis of the baseline data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Clinics (Sao Paulo). 2021, 76:e2370.
XIX. Ohlemiller KK. Mechanisms and genes in human strial presbycusis from animal models. Brain Res. 2009;1277:70-83.
XX. Kakarlapudi V, Sawyer R, Staecker H: The effect of diabetes on sensorineural hearing loss. Otol Neurotol 2003; 24: 382–386.
XXI. Fukushima H, Cureoglu S, Schachern PA, Paparella MM, Harada T, Oktay MF: Effects of type 2 diabetes mellitus on cochlear structure in humans. Arch Otolaryngol Head Neck Surg 2006; 132: 934–938.
XXII. Sugimoto S, Teranishi M, Fukunaga Y, Yoshida T, Sugiura S, Uchida Y, et al. Contributing factors to hearing of diabetic patients in an in-hospital education program. Acta Otolaryngol. 2013;133(11):1165–72.
XXIII. Eren E, Harman E, Arslanoğlu S, Önal K. Effects of type 2 diabetes on optoacoustic emissions and the medial olivocochlear reflex. Otolaryngol Neck Surg. 2014;150(6):1033–9.
XXIV. Calvin D, Watley SR. Diabetes and hearing loss among underserved populations. Nurs Clin North Am. 2015;50(3):449–56.
XXV. Horikawa C, Kodama S, Tanaka S, Fujihara K, Hirasawa R, Yachi Y, et al. Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol Metab. 2013;98(1):51–8.
XXVI. Konrad-Martin D, Reavis KM, Austin D, Reed N, Gordon J, McDermott D, et al. Hearing impairment in relation to severity of diabetes in a veteran cohort. Ear Hear. 2015;36(4):381–94.
XXVII. Hong O, Buss J, Thomas E. Type 2 diabetes and hearing loss. Dis Mon. 2013;59(4):139–46.
XXVIII. Horikawa C, Kodama S, Tanaka S, Fujihara K, Hirasawa R, Yachi Y, Shimano H, Yamada N, Saito K, Sone H: Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol Metab 2013; 98: 51–58.
XXIX. Yikawe SS, Uguru SU, Solomon JH, Adamu AM, Damtong F, Osisi K, et al. Hearing loss among hypertensive patients. Egypt J Otolaryngol. 2019; 35:307–312.
XXX. de Moraes Marchiori LL, de Almeida Rego Filho E, Matsuo T. Hypertension as a factor associated with hearing loss. Braz J Otorhinolaryngol. 2006;72:533–40
XXXI. Babarinde JA, Adeyemo AA, Adeoye AM. Hearing loss and hypertension: exploring the linkage. The Egyptian Journal of Otolaryngology. 2021;37(1):1-6.
XXXII. Baraldi GS, Almeida LC, Borges AC. Hearing loss and hypertension: findings in an elderly group. Braz J Otorhinolaryngol. 2004;70:640-4.
XXXIII. Engdahl B, Aarhus L, Lie A, Tambs K. Cardiovascular risk factors and hearing loss: the HUNT study. Int J Audiol. 2015;54: 958–966.
XXXIV. Agarwal S, Mishra A, Jagade M, Kasbekar V, Nagle SK: Effects of hypertension on hearing. Indian J Otolaryngol Head Neck Surg. 2013, 65:614-8.
XXXV. Hong JW, Jeon JH, Ku CR, et al. The prevalence and factors associated with hearing impairment in the Korean adults: the 2010-2012 Korea National Health and Nutrition Examination Survey (observational study). Medicine 2015;94:e611.
XXXVI. Narlawar UW, Surjuse BG, Thakre SS. Hypertension and hearing impairment in workers of iron and steel industry. Indian J Physiol Pharmacol 2006; 50:60–6.
XXXVII. Yikawe SS, Iseh KR, Sabir AA, lnoh MI, Solomon JH, Aliyu N. Cardiovascular risk factors and hearing loss among adults in a tertiary center of Northwestern Nigeria. World J Otorhinolaryngol Head Neck Surg. 2017; 4(4): 253–257.
XXXVIII. Osuji AE, Da Lilly-Tariah OB, Unachukwu CN, Nwankwo BE. Comparison of Hearing Threshold in Hypertensive and Non Hypertensive Type 2 DM. J Otorhinolaryngol Disord Treat. 2020;1(1): 1-7.
XXXIX. Umesawa M, Sairenchi T, Haruyama Y, Nagao M, Kobashi G. Association between hypertension and hearing impairment in health check-ups among Japanese workers: a cross-sectional study. BMJ open. 2019; 9(4):e028392.
XL. Lim DP, Stephens SD. Clinical investigation of hearing loss in the elderly. Clinical Otolaryngology & Allied Sciences. 1991;16(3):288-93.
XLI. Sebothoma B, Khoza-Shangase K. Investigation of the Interaction between Hearing Function and Comorbidities in Adults Living with Human Immunodeficiency Virus. International journal of environmental research and public health. 2021; 18(22): p.12177.
XLII. Mishra T, Dukhu K, Mohapatra D, Behera M, Priyadarsini N, Panda P, Sahu MC. Hypertension as a risk factor of hearing loss. Int J Pharm Sci Rev Res. 2014;29(1):309-13.
XLIII. Sakamoto M, Sugasawa M, Kaga K, Kamio T. Average thresholds in the 8 to 20 kHz range as a function of age. Scand Audiol. 1998;27(3):189-92,
XLIV. Vemanna P, Patil KI, Prabhu RM, Rao BP, Viswanatha B. Hearing impairment in essential hypertensive patients: a prospective study at a tertiary care center. Research in Otolaryngology. 2019;8(2):20-4.
XLV. Mitchell P, Gopinath B, McMahon CM, Rochtchina E, Wang JJ, Boyages SC, Leeder SR: Relationship of type 2 diabetes to the prevalence, incidence and progression of age-related hearing loss. Diabet Med 2009; 26: 483–488.
XLVI. Duck SW, Prazma J, Bennett PS, Pillsbury HC: Interaction between hypertension and diabetes mellitus in the pathogenesis of sensorineural hearing loss. Laryngoscope 1997; 107:1596–1605.